statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7...

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Nevro price target lowered by $2 at Citi, here's why

Latest Ratings for NVRO
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Wells FargoMaintainsOverweight Feb 2022SVB LeerinkMaintainsOutperform
 View More Analyst Ratings...

Where Nevro Stands With Analysts

This is a Bullish indicator signaling NVRO's price could rise from here. Traders may explore going long the stock or buying call options...

NEVRO (NVRO, $14.09) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 18, 2024

This is a Bearish indicator signaling NVRO's price could decline from here. Traders may explore shorting the stock or put options...

NEVRO (NVRO, $13.73) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 15, 2024

Investors eyeing a purchase of Nevro Corp (NVRO) stock, but tentative about paying the going market price of 13.92/share, might benefit from considering selling puts among the alternative...

Commit To Buy Nevro At $5, Earn 8.9% Annualized Using Options

NEVRO (NVRO, $15.27) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 8, 2024

This is a signal that NVRO's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

NEVRO (NVRO, $14.54) RSI Indicator left the oversold zone on March 06, 2024

Charles Schwab Investment Management Inc. grew its holdings in Nevro Corp. (NYSE:NVRO  Free Report) by 3.7% in the 3rd quarter, according to its most recent disclosure with the Securities and...

Charles Schwab Investment Management Inc. Buys 9,846 Shares of Nevro Corp. (NYSE:NVRO)

StockNews.com upgraded shares of Nevro (NYSE:NVRO  Free Report) from a sell rating to a hold rating in a research report released on Friday morning.
Several other analysts have also recently...

Nevro (NYSE:NVRO) Upgraded at StockNews.com

Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

Volume	373,702.00
52-Wk High	$28.89
52-Wk Low	$10.27

Period	Estimated	Reported	Surprise	Result
Q1'24	-$1.05	--	--	N/A
Q4'23	-$0.49	-$0.25	48.91%	BEAT
Q3'23	-$0.77	-$0.65	15.46%	BEAT
Q2'23	-$0.69	-$0.69	-0.02%	MISSED
Q1'23	-$1.05	-$0.98	6.53%	BEAT

NVRO Nevro Corp

About

Feed

News

Sentiment

Earnings

Fundamentals